Board for Certification in Clinical Anaplastology – Trademark Portfolio
Entity Type: 99
Board for Certification in Clinical Anaplastology holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include CCA, BCCA, and BOARD FOR CERTIFICATION IN CLINICAL ANAPLASTOLOGY. The owner is based in Sykesville, MD.
6708 Senecca Ln
Sykesville, MD 21784
Showing of trademarks Trademarks
Trademark Classifications
Board for Certification in Clinical Anaplastology's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Board for Certification in Clinical Anaplastology have?
Board for Certification in Clinical Anaplastology has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does Board for Certification in Clinical Anaplastology file in?
Board for Certification in Clinical Anaplastology files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Board for Certification in Clinical Anaplastology's most well-known trademarks?
Board for Certification in Clinical Anaplastology's registered trademark portfolio includes well-known marks such as CCA, BCCA, and BOARD FOR CERTIFICATION IN CLINICAL ANAPLASTOLOGY. These are among 3 currently registered trademarks in the portfolio.
What is Board for Certification in Clinical Anaplastology's trademark registration success rate?
Board for Certification in Clinical Anaplastology has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.